Cargando…

Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer

Thyroid cancer is an endocrine malignancy with an incidence rate that has been increasing steadily over the past 30 years. While well-differentiated subtypes have a favorable prognosis when treated with surgical resection and radioiodine, undifferentiated subtypes, such as anaplastic thyroid cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Nicole, Black, Morgan, Patel, Krupal, Yoo, John, Mymryk, Joe S., Barrett, John W., Nichols, Anthony C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170827/ https://www.ncbi.nlm.nih.gov/pubmed/25276134 http://dx.doi.org/10.1155/2014/936285

Ejemplares similares

Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
por: Pinto, Nicole, et al.
Publicado: (2020)

Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
por: Pinto, Nicole, et al.
Publicado: (2018)

Detection of Circulating Tumor DNA in Patients with Thyroid Nodules
por: Patel, Krupal B., et al.
Publicado: (2021)

Does HPV Subtype Predict Outcomes in Head and Neck Cancers?
por: Ziai, Hedyeh, et al.
Publicado: (2021)

Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
por: Mundi, Neil, et al.
Publicado: (2019)

Introduction and expression of PIK3CA(E545K) in a papillary thyroid cancer BRAF(V600E) cell line leads to a dedifferentiated aggressive phenotype
por: Pinto, Nicole, et al.
Publicado: (2022)

High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
por: Gameiro, Steven F., et al.
Publicado: (2019)

Viral Retasking of hBre1/RNF20 to Recruit hPaf1 for Transcriptional Activation
por: Fonseca, Gregory J., et al.
Publicado: (2013)

Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021)

Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection
por: Gameiro, Steven F., et al.
Publicado: (2017)

Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin
por: Gameiro, Steven F., et al.
Publicado: (2017)

Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy
por: Patel, Krupal B., et al.
Publicado: (2018)

Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
por: Zaballos, Miguel A., et al.
Publicado: (2022)

Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer
por: Nichols, Anthony C, et al.
Publicado: (2014)

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
por: Ghasemi, Farhad, et al.
Publicado: (2018)

The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis
por: Salnikov, Mikhail, et al.
Publicado: (2022)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
por: Werner, Michael T., et al.
Publicado: (2017)

Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
por: Ruicci, Kara M., et al.
Publicado: (2019)

Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
por: Ruicci, Kara M., et al.
Publicado: (2019)

Ultra-rare Disease and Genomics-Driven Precision Medicine
por: Lee, Sangmoon, et al.
Publicado: (2016)

Genomics-Driven Precision Medicine in Pediatric Solid Tumors
por: Suthapot, Praewa, et al.
Publicado: (2023)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2020)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
por: Gameiro, Steven F., et al.
Publicado: (2018)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
por: Lee, Jieun, et al.
Publicado: (2013)

TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
por: Ruicci, Kara M., et al.
Publicado: (2020)

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
por: Ghasemi, Farhad, et al.
Publicado: (2017)

SUN-610 Thyroid Storm and Hypoparathyroidism Caused by Anaplastic Thyroid Carcinoma
por: Oben Perez, Laura, et al.
Publicado: (2019)

Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation
por: Patel, K B, et al.
Publicado: (2023)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
por: Kasaian, Katayoon, et al.
Publicado: (2015)

Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling
por: Ravi, Naveen, et al.
Publicado: (2019)

Functional outcomes in early (T1/T2) supraglottic cancer: a systematic review
por: van der Woerd, Benjamin, et al.
Publicado: (2018)

Anaplastic thyroid cancer: How far can we go?
por: Amaral, Mariana, et al.
Publicado: (2020)

Gene master regulators of papillary and anaplastic thyroid cancers
por: Iacobas, Dumitru A., et al.
Publicado: (2017)

Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma Are Molecularly Distinct
por: Sorgini, Alana, et al.
Publicado: (2020)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015)

Anaplastic Thyroid Carcinoma with Gastric Metastasis
por: CHAVEZ, A.A.L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8ha3gmf4pj1peprovkqvp3v21u